New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2014
08:51 EDTECYTEndocyte price target raised to $44 from $24 at Credit Suisse
Credit Suisse raised Enocyte's price target to $44 from $24 following CHMP's recommendation for approval of vintafolide and etarfolatide for platinum resistant ovarian cancer. Shares are Outperform rated.
News For ECYT From The Last 14 Days
Check below for free stories on ECYT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 8, 2014
05:30 EDTECYTEndocyte assumed with a Buy at Brean Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use